Tandem糖尿病護理 TNDM 深 滬
等待開盤 09-20 09:30:00 美东时间
44.45
+1.810
+4.24%
華盛通- 最 高44.58
- 今 開44.29
- 成交量 93.96万股
- 最 低 43.42
- 昨 收 42.64
- 總市值 28.93亿
- 52周最高 53.69
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 13.82
- 委 比 -61.07%
- 總股本 6507.77万
- 歷史最高 302.50
- 量 比 0.96
- 振 幅 2.72%
- 歷史最低 2.14
- 每 手 1
- 風險率 10.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Three ‘buys,’ three ‘sells,’ and a ‘hold,’ by Oppenheimer analysts
Oppenheimer analysts provided insights into seven stocks this morning in a note. Buy-rated stocks: Modine Manufacturing Co. (NYSE:MOD) – The stock continues to have a bullish slope. Tandem Diabetes Ca...
09-13 00:30
Embecta gets FDA clearance for type 2 diabetes patch pump
Embecta (NASDAQ:EMBC) has received FDA clearance for its disposable insulin delivery system for the treatment of both type 1 and type 2 diabetes. The system includes a tubeless patch pump with a 300-u...
09-03 22:24
Top Stock Gainers Today – TNDM, TWLO, and More
As we head into the final 90 minutes of the trading session, these are today’s ...
08-03 02:30
Wells Fargo Keeps Their Buy Rating on Tandem Diabetes Care (TNDM)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Tandem Diabetes ...
08-02 18:53
Essent Group declares $0.28 dividend
Essent Group Ltd. (ESNT) declares $0.28/share quarterly dividend, in line with previous. Forward yield 1.83% Payable Sept. 10; for shareholders of record Aug. 30; ex-div Aug. 29. More on Tandem Diabet...
08-02 18:43
Tandem stock rallies 25% post-market amid raised sales guidance
Shares of Tandem Diabetes Care (NASDAQ:TNDM) rallied 25% in post-market trading Thursday after the company reported better-than-expected Q2 revenue and raised its 2024 sales guidance. After market clo...
08-02 06:02
DexCom reaches a multi-year low as downgrades follow guidance cut
DexCom (NASDAQ:DXCM) shares plunged to the lowest level in more than four years on Friday after the medical device maker slashed its full-year revenue outlook along with its Q2 2024 financials, drawin...
07-27 03:55
Glaukos cut as Citi reviews U.S. MedTechs ahead of Q2 results
Glaukos Corporation (NYSE:GKOS) traded lower on Wednesday after Citi downgraded the glaucoma product maker to neutral from buy as part of a review of its U.S. MedTech coverage ahead of Q2 2024 results...
07-11 00:52
Understanding Tandem Diabetes Care: Joanne Wuensch’s Investment Perspective
Citi analyst Joanne Wuensch has maintained their bullish stance on TNDM stock, ...
07-10 18:18
